NCT01551225View on ClinicalTrials.gov

Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Irritable Bowel SyndromePanic Disorder
Interventions
DRUG

Escitalopram

Patients will start at a dosage of 5 mg daily of escitalopram. After the first week of treatment the dosage will be increased to 10 mg daily. During the visits, the dosage can be gradually increased to a maximum of 20 mg daily, depending on the response of the patient.

Trial Locations (1)

Unknown

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT01551225 - Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder | Biotech Hunter | Biotech Hunter